期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

基质金属蛋白酶和心肌梗死后心室重构 被引量：5

Matrix metalloproteinases and ventricular remodeling after myocardial infarction
下载PDF
导出
摘要 心肌梗死后心室重构是慢性心力衰竭发展的重要病理基础,延缓或阻止心室重构已成为慢性心力衰竭的主要治疗方法。基质金属蛋白酶是一组与心室胞外基质重构有关的水解酶,抑制基质金属蛋白酶的表达和活性对心室重构的防治有重要意义。 Ventricnlar remodeling after myoeardial infarction is important fnndament of heart failure development. Preventing ventrieular remodeling has been a main method for treating chronic heart failure. Matrix metalloproteinases is hydrolyase that is concerned with extracellular matrix remodeling. It has important role for preventing ventricular remodeling by inhibiting expression and activity of matrix metalloproteinases.
作者 洪志斌 问肃生 张远征
机构地区 甘肃省天水市第一人民医院心内科
出处 《国际内科学杂志》 CAS 2009年第1期30-33,共4页 International Journal of Internal Medicine
关键词 基质金属蛋白酶 心肌梗死 心室重构 Matrix metalloproteinases Myocardial infarction Ventricular remodeling
分类号 R542.22 [医药卫生—心血管疾病]
  • 相关文献

参考文献21

  • 1Sun Y, Zhang JQ, Zhang J, et al. Cardiac remodeling by fibrous tissue after infarction in rats. J Lab Clin Med, 2000, 135(4) :316-323.
  • 2Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of matalloproteinases : structure, function, and biochemistry. Circ Res, 2003,92 ( 8 ) : 827-839.
  • 3Auble DT, Brinckerhoff CE. The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase in fibroblasts. Biochemistry, 1991,30(18) :4629-4635.
  • 4Gum R, Lengyel E, Juarez J, et al. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J Biol Chem, 1996,271 (18) : 10672- 10680.
  • 5Halazonetis TD, Georgopoulos K, Greenberg ME, et al. c- Jun dimerizes with itself and with c-Fos, forming complexes of different DNA biding affinities. Cell, 1988,55 ( 6 ) : 917- 924.
  • 6Li YY, McTiernan CF, Feldman AM. Proinflammatory cytokinesregulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cell. Cardiol Res, 1999,42( 1 ) :162-172.
  • 7Ramos-DeSimone N, Hahn-Dantona E, Sipley J, et al. Activation of matrix metalloproteinase-9 ( MMP-1 ) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem, 1999,274(19) : 13066-13076.
  • 8Tyagi SC, Kumar SG, Alla SR, et al. Extrafcellular matrix regulation of metalloproteinase and antiproteinase in human heart fibroblast cells. J Cell Physiol, 1996,167 ( 1 ) : 137- 147.
  • 9Woessner JF. Matrix metalloproteinase inhibition. From the Jurassic to the third millennium. Ann N Y Acad Sci, 1999, 878(2) :388-403.
  • 10Bonnema DD, Webb CS, Pennington WR, et al. Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor ofmetalloproteinases (TIMPs). Card Fail,2007,13 (7) :530-540.

二级参考文献13

  • 1Mori S, Gibson G, McTiernan C F. Differential expression of romps and timps in moderate and severe heart failure in a transgenic model[J]. J Card Fail,2006,12 .-314-325.
  • 2Kawamura N, Kubota T, Kawano S, Monden Y, Feldman A M, Tsutsui H, et al. Blockade of NF-kappaB improves cardiac function and survival without affecting inflammation in TNF- alpha-induced cardiomyopathy [ J ]. Cardiovasc Res, 2005, 66 : 520-529.
  • 3Pratt C M. Three decades of clinical trials with beta-blockers: the contribution of the CAPRICORN trial and the effect of carvedilol on serious arrhythmias[J]. J Am Coll Cardiol,2005, 45:531-532.
  • 4Peterson J T,Li H, Dillon L, Bryant J W. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat [J]. Cardiovasc Res, 2000,46 : 307-315.
  • 5Flack E C,Lindsey M L,Squires C E,Kaplan B S,Stroud R E, Clark L L, et al. Alterations in cultured myocardial fibroblast function following the development of left ventricular failure [J]. J Mol Cell Cardiol,2006,40:474-483.
  • 6Cheung C, Luo H, Yanagawa B, Leong H S, Samarasekera D, Lai J C,et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in coxsackievirus-induced myocarditis[J]. Cardiovasc Pathol, 2006,15 : 63-74.
  • 7Wehrens X H,Doevendans P A. Cardiac rupture complicating myocardial infarction[J]. Int J Cardiol,2004,95:285-292.
  • 8Wang G Y, Bergman M R, Nguyen A P, Turcato S, Swigart P M,Rodrigo M C,et al. Cardiac transgenic matrix metalloproteinase-2 expression directly induces impaired contractility [J]. Cardiovasc Res, 2006,69: 688-696.
  • 9Heymans S, Luttun A, Nuyens D, Theilmeier G,Creemers E, Moons L,et al. Inhibition of plasminogen activators or matrix metalloproteinases prevent cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure[J]. Nat Med, 1999,10:1135-1142.
  • 10Tayebjee M H, Nadar S K, MacFadyen R J, Lip G Y. Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension. Relationship to tissue Doppler indices of diastolic relaxation[J]. Am J Hypertens, 2004,17 : 770-774.

共引文献2

同被引文献63

引证文献5

二级引证文献11

国际内科学杂志
2009年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部